BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 23512196)

  • 1. Mammographic features of calcifications in DCIS: correlation with oestrogen receptor and human epidermal growth factor receptor 2 status.
    Bae MS; Moon WK; Chang JM; Cho N; Park SY; Won JK; Jeon YK; Moon HG; Han W; Park IA
    Eur Radiol; 2013 Aug; 23(8):2072-8. PubMed ID: 23512196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qualitative Radiogenomics: Association Between BI-RADS Calcification Descriptors and Recurrence Risk as Assessed by the Oncotype DX Ductal Carcinoma In Situ Score.
    Woodard GA; Price ER
    AJR Am J Roentgenol; 2019 Apr; 212(4):919-924. PubMed ID: 30714832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening mammography-detected ductal carcinoma in situ: mammographic features based on breast cancer subtypes.
    Kim MY; Kim HS; Choi N; Yang JH; Yoo YB; Park KS
    Clin Imaging; 2015; 39(6):983-6. PubMed ID: 26259866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammographic morphology and distribution of calcifications in ductal carcinoma in situ diagnosed in organized screening.
    Hofvind S; Iversen BF; Eriksen L; Styr BM; Kjellevold K; Kurz KD
    Acta Radiol; 2011 Jun; 52(5):481-7. PubMed ID: 21498306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is There Any Association Between Mammographic Features of Microcalcifications and Breast Cancer Subtypes in Ductal Carcinoma In Situ?
    Avdan Aslan A; Gültekin S; Esendağli Yilmaz G; Kurukahvecioğlu O
    Acad Radiol; 2021 Jul; 28(7):963-968. PubMed ID: 32620528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic, mammographic, and sonographic features in 1,187 patients with pure ductal carcinoma in situ of the breast by estrogen receptor status.
    Rauch GM; Kuerer HM; Scoggins ME; Fox PS; Benveniste AP; Park YM; Lari SA; Hobbs BP; Adrada BE; Krishnamurthy S; Yang WT
    Breast Cancer Res Treat; 2013 Jun; 139(3):639-47. PubMed ID: 23774990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of aggressiveness: risk of progression to invasive breast cancer by mammographic features of calcifications in screen-detected ductal carcinoma in situ.
    Lilleborge M; Falk RS; Hovda T; Holmen MM; Ursin G; Hofvind S
    Acta Radiol; 2022 May; 63(5):586-595. PubMed ID: 33887963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth Dynamics of Mammographic Calcifications: Differentiating Ductal Carcinoma in Situ from Benign Breast Disease.
    Grimm LJ; Miller MM; Thomas SM; Liu Y; Lo JY; Hwang ES; Hyslop T; Ryser MD
    Radiology; 2019 Jul; 292(1):77-83. PubMed ID: 31112087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal alteration of breast cancer receptors between primary ductal carcinoma in situ (DCIS) and corresponding local events.
    Karlsson E; Sandelin K; Appelgren J; Zhou W; Jirström K; Bergh J; Wärnberg F
    Eur J Cancer; 2014 Feb; 50(3):517-24. PubMed ID: 24275214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the Kaiser score on clinical decision-making in BI-RADS 4 mammographic calcifications examined with breast MRI.
    Wengert GJ; Pipan F; Almohanna J; Bickel H; Polanec S; Kapetas P; Clauser P; Pinker K; Helbich TH; Baltzer PAT
    Eur Radiol; 2020 Mar; 30(3):1451-1459. PubMed ID: 31797077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammographic appearance of nonpalpable breast cancer reflects pathologic characteristics.
    Gajdos C; Tartter PI; Bleiweiss IJ; Hermann G; de Csepel J; Estabrook A; Rademaker AW
    Ann Surg; 2002 Feb; 235(2):246-51. PubMed ID: 11807365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of ductal carcinoma in-situ from benign micro-calcifications by dedicated breast computed tomography.
    Aminololama-Shakeri S; Abbey CK; Gazi P; Prionas ND; Nosratieh A; Li CS; Boone JM; Lindfors KK
    Eur J Radiol; 2016 Jan; 85(1):297-303. PubMed ID: 26520874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast ductal carcinoma in situ with micro-invasion versus ductal carcinoma in situ: a comparative analysis of clinicopathological and mammographic findings.
    Zhang M; Lin Q; Su XH; Cui CX; Bian TT; Wang CQ; Zhao J; Li LL; Ma JZ; Huang JL
    Clin Radiol; 2021 Oct; 76(10):787.e1-787.e7. PubMed ID: 34052010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suspicious breast calcifications undergoing stereotactic biopsy in women ages 70 and over: Breast cancer incidence by BI-RADS descriptors.
    Grimm LJ; Johnson DY; Johnson KS; Baker JA; Soo MS; Hwang ES; Ghate SV
    Eur Radiol; 2017 Jun; 27(6):2275-2281. PubMed ID: 27752832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammographic extent of microcalcifications and oestrogen receptor expression affect preoperative breast carcinoma in situ size estimation.
    Vernet-Tomas M; Mojal S; Gamero R; Nicolau P; Rodríguez-Arana A; Plancarte F; Corominas JM; Serrano-Munne L; Carreras R; Sabadell D
    Breast Cancer; 2017 May; 24(3):466-472. PubMed ID: 27639877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammographic predictors of the presence and size of invasive carcinomas associated with malignant microcalcification lesions without a mass.
    Stomper PC; Geradts J; Edge SB; Levine EG
    AJR Am J Roentgenol; 2003 Dec; 181(6):1679-84. PubMed ID: 14627596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of mammographic calcifications with Her-2/neu overexpression in primary breast carcinomas.
    Wang X; Chao L; Chen L; Tian B; Ma G; Zang Y; Hua M; Sun J
    J Digit Imaging; 2008 Jun; 21(2):170-6. PubMed ID: 18256879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixed-Methods Study to Predict Upstaging of DCIS to Invasive Disease on Mammography.
    Grimm LJ; Neely B; Hou R; Selvakumaran V; Baker JA; Yoon SC; Ghate SV; Walsh R; Litton TP; Devalapalli A; Kim C; Soo MS; Hyslop T; Hwang ES; Lo JY
    AJR Am J Roentgenol; 2021 Apr; 216(4):903-911. PubMed ID: 32783550
    [No Abstract]   [Full Text] [Related]  

  • 19. Breast microcalcifications: the UK RCR 5-point breast imaging system or BI-RADS; which is the better predictor of malignancy?
    Metaxa L; Healy NA; O'Keeffe SA
    Br J Radiol; 2019 Nov; 92(1103):20190177. PubMed ID: 31365279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simplifying Breast Imaging Reporting and Data System classification of mammograms with pure suspicious calcifications.
    Menezes GL; Winter-Warnars GA; Koekenbier EL; Groen EJ; Verkooijen HM; Pijnappel RM
    J Med Screen; 2018 Jun; 25(2):82-87. PubMed ID: 28691862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.